DWM
NMTC icon

Drive Wealth Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Drive Wealth Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,730
Closed -$55.4K – 305
2023
Q1 		$55.4K Sell
5,730
-4,971
-46% -$46.1K 0.02% 285
2022
Q4 		$77K Sell
10,701
-410
-4% -$3.67K 0.04% 240
2022
Q3 		$113K Hold
11,111
– – 0.11% 148
2022
Q2 		$55K Hold
11,111
– – 0.05% 165
2022
Q1 		$73K Hold
11,111
– – 0.06% 162
2021
Q4 		$129K Buy
+11,111
New +$180K 0.11% 150

Other funds holding NMTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return

Drive Wealth Management's NMTC Position: Q2 2023 in Review

Drive Wealth Management sold out of NeuroOne Medical Technologies (NMTC) in Q2 2023, closing a stake of 5,730 shares — an estimated $55.4K sold.

Drive Wealth Management first reported a position in NMTC in Q4 2021 and held it in 6 quarters. The position peaked at $129K in Q4 2021. 14 funds tracked by Wall St. Rank hold NMTC as of Q2 2023.

  • Drive Wealth Management reported no remaining NeuroOne Medical Technologies position as of Q2 2023 after selling out during the quarter.
  • Drive Wealth Management sold 5,730 NeuroOne Medical Technologies shares in Q2 2023, an estimated $55.4K.
  • Drive Wealth Management first reported a position in NeuroOne Medical Technologies in Q4 2021 and held it in 6 quarters.
  • Drive Wealth Management's NeuroOne Medical Technologies position peaked at $129K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2023.

Based on Drive Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.